Table 4.

Interaction between faces displaying direct and averted gaze in the placebo and oxytocin group [(CSdg+ vs CSdg) vs (CSag+ vs CSag)]

Placebo groupOxytocin groupDifference placebo > oxytocin group
Coordinatest valuep valueCoordinatest valuep valueCoordinatest valuep value
Amy20, 0, −203.94<0.05*20, 0, −203.55<0.05*
Amy−18, −8, −262.56NS
R Insula30, 30, −103.66<0.001
R FFA42, −50, −14−4.58<0.00142, −50, −143.59<0.001
cACC14, 0, 403.89<0.001
−12, −2, 484.04<0.001
mObfc16, 44, −183.89<0.001
rACC/vmPFC4, 62, 0−5.60<0.0014, 62, 04.16<0.001
vlPFC34, 62, 43.73<0.001
vlPFC46, 50, 44.37<0.001
  • Amy, Amygdala; FFA, fusiform face area; cACC, caudal anterior cingulate cortex; mObfc, medial orbitofrontal cortex; rACC, rostral anterior cingulate cortex; vmPFC, ventromedial prefrontal cortex; vlPFC, ventrolateral prefrontal cortex; R, right; NS, nonsignificant. *Small volume corrected.